Biotage

Remuneration Information • Oct 21, 2022

Issue and re-purchase of class C shares for incentive program

The Board of Directors of Biotage AB (publ) ("Biotage") has today resolved, by virtue of the authorisation by the Annual General Meeting held on April 28, 2022, to issue and immediately thereafter re-purchase 243,252 class C shares. The shares are issued and re-purchased in accordance with the incentive program LTIP 2022 which was adopted by the Annual General Meeting held on April 28, 2022.

Danske Bank A/S, Danmark, Sverige Filial, will subscribe for the entire issue of new class C shares at a subscription price of SEK 1.39 per share, corresponding to the quota value of the shares. The entire issue of class C shares will thereafter, in accordance with the Board of Directors' resolution, be re-purchased by Biotage for the same price. The class C shares will be converted into ordinary shares prior to delivery to qualifying participants of LTIP 2022.

The purpose of the re-purchase is to ensure delivery of shares to participants and to secure social contributions arising as a result of LTIP 2022. The class C shares do not entitle to dividends and each share entitles to 1/10 voting right.

Contacts

Tomas Blomquist, President and CEO Tel: 0705 23 01 63, tomas.blomquist@biotage.com

About Biotage

Biotage is a Global Impact Tech Company committed to solving society's problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.

Biotage is contributing to sustainable science with the goal to make the world a healthier, greener and cleaner place – HumanKind Unlimited.

Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage's share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm. Website: www.biotage.com

Attachments

Issue and re-purchase of class C shares for incentive program